drugset / Trial / NCT00431054
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find out if a combination treatment of perifosine and docetaxel will help shrink or slow the growth of cancer cells in recurrent ovarian cancer. The safety of this combination treatment will also be studied.
Timeline
- Start
- 2007-02
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |
| Subject | Perifosine | Small molecule | 50 mg | Oral |